On Tuesday, September 23, shares of 8 companies will be monitored in the stock market. Important updates related to them have come out. These companies include government and private sector legendary companies. Let’s know about the shares being in the eyes of investors in Tuesday’s trading session.
RVNL
Government Railway Company- Rail Development Corporation Limited (RVNL) said on Monday that it has received an order of Rs 145.34 crore from Southern Railway. The objective of this project is to improve the infrastructure and power supply system of the railway. The stock fell 1.11% to close at Rs 359.40.
Glenmark Pharma
The pharmaceutical company Glenmark Pharmaceuticals Limited said that the company’s board will meet on 26 September 2025. In this, interim dividends will be considered on equity shares for FY 2025-26. If the dividend is declared, the record date is set 30 September 2025. The company’s shares closed at Rs 2,022 with a decline of 3.03% on Monday.
Birla Corporation
RCCPL Private Limited, a company owned by Birla Corporation, has won the bid for Guda-Rampur Limestone and Manganese blocks by the Department of Mines and Geology, Telangana. This block is spread over an area of 3.34 square kilometers in Adilabad district.
Alchem laboratories
Alchem Laboratories Limited has announced the launch of ‘Partuza’, a new drug of breast cancer in India. This 420 mg/14 ml injection will ensure better access to Her2 positive patients and cancer care. The company’s shares closed at Rs 5,486 on Monday at Rs 5,486.
TCS
IT sector veteran Tata Consultancy Services (TCS) will release the results of its second quarter (second quarter of FY 2025-26) on 9 October 2025. Subsequently, the company will talk to the media and a conference call with investors. TCS has performed well in recent quarters. The stock fell 2.96% to close at Rs 3,075.50 on Friday.
Brigade enterprises
Brigade Enterprises Limited has signed an agreement for a new residential project with a gross growth price of Rs 1,200 crore on 7.5 acres of land in South Bengaluru. The company says the project will strengthen its appearance in Bengaluru Real Estate. The stock fell 1.32% to close at Rs 924.95 on Monday.
Dr. Reddy’s
Dr. Reddy’s Laboratories Limited has reported positive response from the EMA’s CHMP for AVT 03 (Danosumab). The company’s stock fell 1.48% to close at Rs 1,302.10 on Monday.
The company denied reports that General Atlantic is planning to sell its stake. The company clarified that no such plan or negotiation is going on at the moment. The company fell 5.21% to close at Rs 1,090 on Monday.
